======= UGT8 ======= == Gene Information == * **Official Symbol**: UGT8 * **Official Name**: UDP glycosyltransferase 8 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7368|7368]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q16880|Q16880]] * **Interactions**: [[https://thebiogrid.org/search.php?search=UGT8&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20UGT8|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601291|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Catalyzes the transfer of galactose to ceramide, a key enzymatic step in the biosynthesis of galactocerebrosides, which are abundant sphingolipids of the myelin membrane of the central nervous system and peripheral nervous system. {ECO:0000250|UniProtKB:Q09426}. |Glyco tran 28 C| |UDPGT| |N-acylsphingosine galactosyltransferase activity| |UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity| |protein localization to paranode region of axon| |galactosylceramide biosynthetic process| |galactolipid biosynthetic process| |glycosylceramide biosynthetic process| |paranodal junction assembly| |protein localization to axon| |galactosylceramide metabolic process| |galactolipid metabolic process| |glycosylceramide metabolic process| |myelin assembly| |UDP-glycosyltransferase activity| |glycosphingolipid biosynthetic process| |ceramide biosynthetic process| |glycosphingolipid metabolic process| |glycolipid biosynthetic process| |peripheral nervous system development| |ceramide metabolic process| |sphingolipid biosynthetic process| |cellular component assembly involved in morphogenesis| |cell-cell junction assembly| |myelination| |axon ensheathment| |ensheathment of neurons| |glycolipid metabolic process| |liposaccharide metabolic process| |membrane lipid biosynthetic process| |cell-cell junction organization| |sphingolipid metabolic process| |cell junction assembly| |membrane lipid metabolic process| |cell junction organization| |neuron projection morphogenesis| |plasma membrane bounded cell projection morphogenesis| |cell projection morphogenesis| |cell part morphogenesis| |amide biosynthetic process| |lipid biosynthetic process| |carbohydrate derivative biosynthetic process| |neuron projection development| |intracellular membrane-bounded organelle| |cell morphogenesis| |cellular amide metabolic process| |neuron development| |cellular component morphogenesis| |anatomical structure formation involved in morphogenesis| |cellular lipid metabolic process| |central nervous system development| |neuron differentiation| |carbohydrate derivative metabolic process| |cytoskeleton organization| |plasma membrane bounded cell projection organization| |cell projection organization| |lipid metabolic process| |organonitrogen compound biosynthetic process| |generation of neurons| |cellular protein localization| |cellular macromolecule localization| |neurogenesis| |cellular nitrogen compound biosynthetic process| |cell development| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-2.17| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18083 * **Expression level (log2 read counts)**: 2.47 {{:chemogenomics:nalm6 dist.png?nolink |}}